Seoul, South Korea

Hyoungkyu Son

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hyoungkyu Son: Innovator in Substrate Treatment Technology

Introduction

Hyoungkyu Son is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of substrate treatment technology, holding three patents that showcase his innovative approach to enhancing plasma treatment processes.

Latest Patents

Hyoungkyu Son's latest patents include a "Support unit and apparatus for treating substrate" and a "Substrate treating apparatus and substrate support unit." The first patent provides a support unit included in an apparatus for treating a substrate using plasma. This support unit is designed to support the substrate and features a power supply rod connected to a high-frequency power supply, an electrode plate that receives power from the rod, and a ground ring that surrounds the electrode plate. The second patent relates to a substrate support unit that includes a dielectric plate for substrate placement, a lower electrode with a specific diameter, and a power supply rod that applies RF power to the lower electrode. This innovative design enhances the efficiency of substrate treatment processes.

Career Highlights

Hyoungkyu Son is currently employed at Semes Co., Ltd., where he continues to develop advanced technologies in substrate treatment. His work has positioned him as a key figure in the industry, contributing to the advancement of plasma treatment applications.

Collaborations

Hyoungkyu Son collaborates with talented individuals such as Hyeon Gyu Kim and Won Seok Lee. Their combined expertise fosters a creative environment that drives innovation in their projects.

Conclusion

Hyoungkyu Son's contributions to substrate treatment technology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in plasma treatment processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…